---
figid: PMC11863469__12943_2025_2267_Fig10_HTML
figtitle: PI3K/AKT/mTOR pathway in GBM progression
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11863469
filename: 12943_2025_2267_Fig10_HTML.jpg
figlink: /pmc/articles/PMC11863469/figure/F10/
number: F10
caption: The PI3K/AKT/mTOR pathway in GBM progression. This pathway plays a critical
  role in GBM progression. Elevated glucose levels increase the ATP/AMP ratio, inhibiting
  AMPK, which normally suppresses mTORC1. This inhibition activates mTORC1, driving
  protein synthesis, cell growth, and proliferation. RTKs activate PI3K, converting
  PIP2 to PIP3, which activates AKT, a central regulator of cell survival and growth.
  The loss of PTEN, a tumor suppressor, results in sustained AKT activation, leading
  to uncontrolled signaling. AKT promotes GBM cell survival by inhibiting apoptosis
  through the phosphorylation of targets such as BAD and GSK3. Under hypoxic conditions,
  HIF1 and VEGF interact with this pathway to enhance angiogenesis and metabolic adaptation,
  contributing to tumor aggressiveness. Inhibitors like TORIN and Rapalogs offer potential
  therapeutic strategies by targeting mTOR-dependent signaling in GBM
papertitle: 'Glioblastoma multiforme: insights into pathogenesis, key signaling pathways,
  and therapeutic strategies'
reftext: Ashkan Pouyan, et al. Mol Cancer. 2025;24(NA).
year: '2025'
doi: 10.1186/s12943-025-02267-0
journal_title: Molecular Cancer
journal_nlm_ta: Mol Cancer
publisher_name: BMC
keywords: Glioblastoma multiforme | Signaling pathways | Therapeutic resistance |
  Molecular mechanisms | Targeted therapy
automl_pathway: 0.9486167
figid_alias: PMC11863469__F10
figtype: Figure
redirect_from: /figures/PMC11863469__F10
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11863469__12943_2025_2267_Fig10_HTML.html
  '@type': Dataset
  description: The PI3K/AKT/mTOR pathway in GBM progression. This pathway plays a
    critical role in GBM progression. Elevated glucose levels increase the ATP/AMP
    ratio, inhibiting AMPK, which normally suppresses mTORC1. This inhibition activates
    mTORC1, driving protein synthesis, cell growth, and proliferation. RTKs activate
    PI3K, converting PIP2 to PIP3, which activates AKT, a central regulator of cell
    survival and growth. The loss of PTEN, a tumor suppressor, results in sustained
    AKT activation, leading to uncontrolled signaling. AKT promotes GBM cell survival
    by inhibiting apoptosis through the phosphorylation of targets such as BAD and
    GSK3. Under hypoxic conditions, HIF1 and VEGF interact with this pathway to enhance
    angiogenesis and metabolic adaptation, contributing to tumor aggressiveness. Inhibitors
    like TORIN and Rapalogs offer potential therapeutic strategies by targeting mTOR-dependent
    signaling in GBM
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EIF4E
  - EIF4E2
  - EIF4E3
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ATP8A2
  - APRT
  - MFAP1
  - AKT1
  - AKT2
  - AKT3
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - RPS6KB1
  - MTOR
  - RPTOR
  - MLST8
  - DEPTOR
  - AKT1S1
  - EIF4EBP1
  - PTEN
  - TSC1
  - CCL26
  - TSC2
  - MTG1
  - RHEB
  - RHEBP1
  - BAD
  - GSK3A
  - GSK3B
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - MAPKAP1
  - RICTOR
  - Amino acids
  - Glucose
  - Raptor
  - GTP
  - GDP
  - Signal molecule
  - Glioblastoma
  - glioblastoma
  - cancer
---
